
Novo Nordisk (NVO) Market Capitalization Overview
Market Cap: $232.34B as of Jun 30, 2025
$232.34B
Past Month-$1.49B (0.63%)
As of Jun 30, 2025, Novo Nordisk (NVO) has a market capitalization of $232.34B. Over the past 30 days, its market cap has increased by 11.09%, while in the last 12 months, it has decreased by -19.1%.
Market capitalization represents the total value of Novo Nordisk as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Novo Nordisk (NVO) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Novo Nordisk (NVO) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Novo Nordisk as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Novo Nordisk (NVO) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Novo Nordisk (NVO) helps investors assess the company's size and compare it with competitors for better investment decisions.
Novo Nordisk (NVO) Market Cap & Key Trends
See Novo Nordisk’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Novo Nordisk (NVO)
Order type
Buy in
Order amount
Est. shares
0 shares
Novo Nordisk (NVO) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $245.16B | +11.09% |
May 1, 2025 | $220.70B | -3.57% |
Apr 1, 2025 | $228.87B | -23.88% |
Mar 3, 2025 | $300.66B | +8.96% |
Feb 3, 2025 | $275.93B | -5.56% |
Jan 2, 2025 | $292.18B | -19.46% |
Novo Nordisk (NVO) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $232.34B | -19.10% |
2024 | $287.18B | -18.01% |
2023 | $350.24B | +51.70% |
2022 | $230.88B | +18.34% |
2021 | $195.10B | +57.31% |
2020 | $124.02B | — |
FAQs About Novo Nordisk (NVO) Market Cap
As of Jun 30, 2025, the market capitalization of Novo Nordisk (NVO) is $232.34B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Novo Nordisk’s market capitalization has decreased by -0.6300%, changing from $233.82B to $232.34B as of Jun 30, 2025.
In the last 3 months, Novo Nordisk’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Novo Nordisk’s market capitalization decreased from $350.24B in January to $287.18B in December, reflecting a -18.01% change.
In the past five years, Novo Nordisk (NVO) has had a compound annual growth rate (CAGR) of 18.29% in market capitalization. This means its market cap has grown at an average rate of 18.29% per year.